GB9724817D0 - Transdermal dosage form - Google Patents
Transdermal dosage formInfo
- Publication number
- GB9724817D0 GB9724817D0 GBGB9724817.3A GB9724817A GB9724817D0 GB 9724817 D0 GB9724817 D0 GB 9724817D0 GB 9724817 A GB9724817 A GB 9724817A GB 9724817 D0 GB9724817 D0 GB 9724817D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- dosage form
- transdermal dosage
- transdermal
- dosage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9724817.3A GB9724817D0 (en) | 1997-11-24 | 1997-11-24 | Transdermal dosage form |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9724817.3A GB9724817D0 (en) | 1997-11-24 | 1997-11-24 | Transdermal dosage form |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9724817D0 true GB9724817D0 (en) | 1998-01-21 |
Family
ID=10822561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9724817.3A Ceased GB9724817D0 (en) | 1997-11-24 | 1997-11-24 | Transdermal dosage form |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB9724817D0 (en) |
-
1997
- 1997-11-24 GB GBGB9724817.3A patent/GB9724817D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA983176B (en) | Therapeutic compounds | |
HUP0002162A3 (en) | Dose setting device | |
GB9801363D0 (en) | Novel dosage form | |
ZA987551B (en) | Solid pharmaceutical dosage forms | |
GB9700504D0 (en) | Pharmaceutical compounds | |
EP0978288A4 (en) | Medicinal composition | |
EP1003495A4 (en) | Pharmaceutical compounds | |
GB9716244D0 (en) | Pharmaceutical compounds | |
GB9722031D0 (en) | Identifiable substances | |
PL338781A1 (en) | Dosage form | |
IL122920A (en) | Castrointestinal drug composition | |
GB9716345D0 (en) | Therapeutic compounds | |
ZA98300B (en) | Pharmaceutical compounds | |
GB9716347D0 (en) | Therapeutic compounds | |
GB9716344D0 (en) | Therapeutic compounds | |
ZA982395B (en) | Therapeutic composition | |
GB9724817D0 (en) | Transdermal dosage form | |
GB9718683D0 (en) | Novel dosage form | |
GB9409289D0 (en) | Transdermal dosage form | |
GB9409235D0 (en) | Transdermal dosage form | |
GB9719261D0 (en) | Dosage forms | |
GB9704978D0 (en) | Dosage forms | |
GB9708698D0 (en) | Materials for therapy | |
GB9803032D0 (en) | Transdermal delivery devices | |
GB2329335B (en) | Medicament |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |